ITMI951409A1 - USE OF POTASSIUM AND MAGNESIUM L-ASPARTATE TO INCREASE BLOOD GLUTAMINE CONCENTRATION - Google Patents
USE OF POTASSIUM AND MAGNESIUM L-ASPARTATE TO INCREASE BLOOD GLUTAMINE CONCENTRATIONInfo
- Publication number
- ITMI951409A1 ITMI951409A1 IT95MI001409A ITMI951409A ITMI951409A1 IT MI951409 A1 ITMI951409 A1 IT MI951409A1 IT 95MI001409 A IT95MI001409 A IT 95MI001409A IT MI951409 A ITMI951409 A IT MI951409A IT MI951409 A1 ITMI951409 A1 IT MI951409A1
- Authority
- IT
- Italy
- Prior art keywords
- aspartate
- magnesium
- potassium
- increase blood
- glutamine concentration
- Prior art date
Links
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 title abstract 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 title abstract 2
- RXMQCXCANMAVIO-CEOVSRFSSA-L magnesium;(2s)-2-amino-4-hydroxy-4-oxobutanoate Chemical compound [H+].[H+].[Mg+2].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O RXMQCXCANMAVIO-CEOVSRFSSA-L 0.000 title abstract 2
- 239000011591 potassium Substances 0.000 title abstract 2
- 229910052700 potassium Inorganic materials 0.000 title abstract 2
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Si descrive l'uso di L - aspartato di potassio e di magnesio per la fabbricazione di un medicamento utile per il trattamento degli stati di carenza di glutammina.The use of potassium and magnesium L - aspartate for the manufacture of a medicament useful for the treatment of glutamine deficiency states is described.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MI001409A ITMI951409A1 (en) | 1995-06-30 | 1995-06-30 | USE OF POTASSIUM AND MAGNESIUM L-ASPARTATE TO INCREASE BLOOD GLUTAMINE CONCENTRATION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MI001409A ITMI951409A1 (en) | 1995-06-30 | 1995-06-30 | USE OF POTASSIUM AND MAGNESIUM L-ASPARTATE TO INCREASE BLOOD GLUTAMINE CONCENTRATION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITMI951409A0 ITMI951409A0 (en) | 1995-06-30 |
| ITMI951409A1 true ITMI951409A1 (en) | 1996-12-30 |
Family
ID=11371902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT95MI001409A ITMI951409A1 (en) | 1995-06-30 | 1995-06-30 | USE OF POTASSIUM AND MAGNESIUM L-ASPARTATE TO INCREASE BLOOD GLUTAMINE CONCENTRATION |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | ITMI951409A1 (en) |
-
1995
- 1995-06-30 IT IT95MI001409A patent/ITMI951409A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI951409A0 (en) | 1995-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE71947T1 (en) | TETRAPYRROL THERAPY AGENT. | |
| TR199902803T2 (en) | Compounds and methods for narrowing the diagnosis of VCAM-1. | |
| ES2191102T3 (en) | USEFUL PEPTIDYL HETEROCICLES IN THE TREATMENT OF THROMBIN-RELATED AFFECTIONS. | |
| ZA981936B (en) | Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase. | |
| AP9600804A0 (en) | Therapeutic amides. | |
| AU1373499A (en) | Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease | |
| NZ306694A (en) | Skin care composition containing a retinoid | |
| EP2044938A3 (en) | Radioprotectors | |
| EP0982988A4 (en) | Substantially pure zonulin, a physiological modulator of mammalian tight junctions | |
| BG102024A (en) | Ammoxycillin and clavulanic acid containing composition | |
| IT1293778B1 (en) | 1,4,7,10-TETRAAZABICICLO (8.2.2.)TETRADECAN-2 ONE, ITS PREPARATION AND USE FOR THE PREPARATION OF TETRAAZAMACROCYCLES | |
| TR199701414T1 (en) | Medical device that adheres to the skin. | |
| IT1274156B (en) | "L-CARNITINE SALT AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT FOR THE TREATMENT OF SKIN DISEASES" | |
| ES2153113T3 (en) | BENZOTIOPHENE COMPOUNDS. | |
| GB2380939B (en) | Treatment or prevention of auto-immune diseases | |
| HUP9802206A1 (en) | Intravenous thaidomid composition for treating immunological diseases | |
| TW372238B (en) | N-[(1,4-diazabicyclo[2.2.2]oct-2-yl)methyl]benzamide derivatives, their preparation and their application in therapeutics | |
| ATE234083T1 (en) | USE OF AMINOADAMANTAN COMPOUNDS AS IMMUNE REGULATORS | |
| IT1274157B (en) | "L-CARNITINE SALT AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT FOR THE TREATMENT OF SKIN DISEASES" | |
| NO934197L (en) | Vitamin D-3 analogues | |
| ITMI951409A1 (en) | USE OF POTASSIUM AND MAGNESIUM L-ASPARTATE TO INCREASE BLOOD GLUTAMINE CONCENTRATION | |
| ES2149448T3 (en) | THERAPEUTIC AND ANALYTICAL AGENTS. | |
| ES2074264T3 (en) | HYDROQUINONE AMINO ACID ESTERS, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL OR COSMETIC COMPOSITIONS CONTAINING THEM. | |
| BE899634A (en) | COSMETIC COMPOSITION FOR THE TREATMENT OF HAIR AND SKIN, CONTAINING OXATHIAZINONES. | |
| IT1242475B (en) | COLINERGIC AGENT, IN PARTICULAR GLYCIL-P-AMINO-PYRIDINE-ANYLIDE-MONOACETATE, FOR THE TREATMENT OF SENILE STATE OF DEEMENT. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0003 | Withdrawn |